This Bone Cell Therapy Could Make it to a Shelf Near You
Bone Therapeutics (Belgium) is almost finished with the phase IIa trial for a Spinal cell…
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Bone Therapeutics (Belgium) is almost finished with the phase IIa trial for a Spinal cell…
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College…
The MIT spin-off SQZ Biotech has an invention (Cell SQueeZe) which could make vector drug delivery…
Adaptimmune has initiated a phase I/II safety and tolerability study of its affinity enhanced T-cell…
That's what Zami Aberman, CEO of one of the world-leading cell-therapy company Pluristem told me during…
Monday: Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer Tuesday: What the FUGT? We tried…
Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford's…
Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany),…
This week, we're leaving Paris and heading East to a city that's 9 times bigger than…
Artificial three-dimensional tissues to regenerate bones and soft tissues: Novadip Biosciences’ dream is a step…
Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer,…
Munich-based Medigene is planning to raise cash through existing shareholders’ investments. The company targets up…